AI Is Changing Antibody Engineering in the Biopharmaceutical Industry As the biopharmaceutical industry explores innovative and novel ways to handle the complexities of drug formulation, artificial intelligence (AI) technology is experiencing a marked rise in incorporation. Processor-intensive tasks such as antibody engineering, which were once hindered by time and resource constraints, are now becoming quicker and more efficient thanks to AI.
...
0 Shares
1240 Views
0 Reviews